Sizheng Steven Zhao, MBChB(Hons), MRCP, from the University of Liverpool, answers our questions about his study of the prevalence of mental health disorders among individuals with psoriatic arthritis.
Dr Laitman discusses evidence supporting the reclassification of schizophrenia as a neurological disorder, his views on how reclassification could impact prognosis and recovery, and treatment interventions...
In this commentary, Dr Rebecca Gottesman reviews the results of her ARIC-PET amyloid imaging study and explains what they mean for the future of clinical practice.
Consultant360 spoke with Leslie Heinberg, PhD, from Cleveland Clinic, about the importance of cognitive behavioral therapy and a multidisciplinary approach to treating obesity, especially among those with...
Michael Genovese, MD, JD, chief medical advisor of Acadia Healthcare's Recovery Division, explains how performing a DNA analysis could help physicians select treatment options for depression that are right...
Eileen O’Grady, PhD, NP, RN, founder of the School of Wellness, discusses intentional change, positive psychology, and similar mental health initiatives in relation to the PERMA model.
Eileen O’Grady, PhD, NP, RN, founder of the School of Wellness, discusses intentional change, positive psychology, and similar mental health initiatives in relation to the PERMA model.
In the final installment of this podcast series, Robert S. Laitman, MD, from Bronx Westchester Medical Group and SARDAA discusses suicidality in patients with schizophrenia compared with the general...
